Open access · CC-BY
via OpenAlex
Age-related synaptic vesicle dysfunction as a prodromal target in Parkinson’s disease: Mechanistic insights from alpha-synuclein biology
Aging advances. · 2026
Loss of proteostasis
Mitochondrial dysfunction
Disabled macroautophagy
Cell culture / in vitro
Human
In vitro
Review
Abstract
Aging is the principal biological driver of Parkinson’s disease and provides the molecular context in which α-synuclein transitions from a physiological presynaptic organizer to a pathological mediator of synaptic failure. Age-related declines in mitochondrial efficiency, lipid homeostasis, proteostasis(definition), and autophagic flux disrupt synaptic vesicle architecture and function—lowering the threshold for α-synuclein misfolding, membrane dysregulation, and toxic gain-of-function. In this vulnerable presynaptic environment, neurons become functionally compromised long before cell death occurs, creating a prolonged prodromal window in which early therapeutic intervention may be most effective. This narrative review synthesizes mechanistic evidence from human studies, animal models, and in vitro systems, indicating that α-synuclein regulates synaptic vesicle clustering, curvature stabilization, and neurotransmitter release under physiological conditions, but that age-dependent alterations in lipid composition, phosphatidylserine asymmetry, oxidative stress, and autophagy(definition) promote its mislocalization and aggregation. These changes generate early presynaptic disturbances—including depletion of synaptophysin and vesicle-associated membrane protein 2, impaired vesicle docking and release probability, and reduced neurotransmission efficiency—that precede dopaminergic degeneration and clinical symptoms. Human biofluid studies demonstrate that vesicle-associated proteins and lipids reflect these early alterations and may serve as accessible biomarkers of impending disease. Current research, however, is limited by the predominant use of young animal models, insufficient mimicry of the aging microenvironment, and a lack of longitudinal approaches capable of resolving dynamic synaptic vesicle changes across the lifespan. The evidence reviewed here supports reframing Parkinson’s disease as an aging-dependent synaptopathy in which presynaptic vulnerability represents the earliest actionable stage of disease. Targeting age-related synaptic vesicle dysfunction and maintaining synaptic homeostasis may offer a pathway toward delaying or preventing the progression from prodromal states to clinically manifest Parkinson’s disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4103/agingadv.agingadv-d-25-00021
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Arias-Carrión, �. (2026). Age-related synaptic vesicle dysfunction as a prodromal target in Parkinson’s disease: Mechanistic insights from alpha-synuclein biology. <em>Aging advances.</em>. https://doi.org/10.4103/agingadv.agingadv-d-25-00021
Vancouver
Arias-Carrión �. Age-related synaptic vesicle dysfunction as a prodromal target in Parkinson’s disease: Mechanistic insights from alpha-synuclein biology. Aging advances.. 2026. doi:10.4103/agingadv.agingadv-d-25-00021.
BibTeX
@article{scar2026Agerel,
title = {Age-related synaptic vesicle dysfunction as a prodromal target in Parkinson’s disease: Mechanistic insights from alpha-synuclein biology},
author = {Óscar Arias-Carrión},
journal = {Aging advances.},
year = {2026},
doi = {10.4103/agingadv.agingadv-d-25-00021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009
Open access · OA
Mitochondrial dysfunction in Parkinson's disease
biorxiv 2024
Preprint · CC-BY
Increasing the vitamin C transporter SVCT2 in microglia improves synaptic plasticity and restrains memory impairments in Alzheimer's disease models
Cold Spring Harbor Perspectives in Medicine 2011
Preprint · OA
Mitochondrial Biology and Parkinson's Disease
Molecular Neurodegeneration 2023
Open access · CC-BY
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Free Radical Biology and Medicine 2016
Preprint · OA
Mitochondrial control of cell bioenergetics in Parkinson’s disease
Molecular Neurobiology 2013
Open access · OA